SEARCH RESULTS FOR: "Tag: NKTR"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(9)
2017(3)
2015(1)
CATEGORIES
Analyst Update(2)
Best and Worst Stocks(2)
Buzz Stocks(5)
Earnings Preview(1)
Editor's Pick(2)
General(1)
Midday Market Check(2)
Quantitative Analysis(2)
Stocks On the Move(2)
Technical Analysis(3)

8/9/2019 10:04 AM
Nektar Therapeutics (NASDAQ:NKTR) stock opened at its lowest level since mid-2017 today -- down 36% at $18.01 -- after the drugmaker unveiled manufacturing issues with bempeg, its experimental cancer ...
8/1/2019 12:19 PM
A big winner out of the healthcare sector today is Nektar Therapeutics (NASDAQ:NKTR), after the Food and Drug Administration (FDA) granted "breakthrough" therapy status to the company's lead cancer dr...
5/16/2019 12:06 PM
The Dow Jones Industrial Average (DJI) is soaring today, up over 250 points and barreling toward its third straight win, thanks to a combination of well-received blue-chip earnings and upbeat eco...
12/18/2018 2:37 PM
The Federal Open Market Committee (FOMC) kicked off its two-day policy-setting meeting today, with the central bank widely expected to announce another rate hike tomorrow afternoon -- despite protests...
11/12/2018 3:13 PM
Losses for the U.S. stock market are stiff in the second half of the session, with a sharp sell-off for big-cap bank stock Goldman Sachs Group Inc (NYSE:GS) dragging on the Dow. Among other names mak...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center